Biosino Bio-Technology and Science Incorporation has unveiled plans to appoint and re-appoint a total of seven directors for its ninth session of the Board. The proposal includes re-appointing three executive directors, two independent non-executive directors, and adding one new non-executive director and one new independent non-executive director. If approved, the Board’s size will be reduced from nine to seven members, with one chairman and one vice-chairman.

Accompanying these proposed board changes are amendments to the Articles of Association and the Rules of Procedure of the Board of Directors, specifically reflecting the streamlined composition. Shareholders will consider these proposals at the Company’s Extraordinary General Meeting, scheduled for 9 February 2026 at 10:00 a.m. in Beijing, as detailed in the official notice.